Caribou Biosciences, Inc. (CRBU) - Latest Market Data

Price & Market Data

Price: $2.11

Daily Change: +$0.12 / 5.69%

Daily Range: $1.94 - $2.12

Market Cap: $208,279,200

Daily Volume: 1,396,555

Performance Metrics

1 Week: -4.93%

1 Month: -11.57%

3 Months: 15.71%

6 Months: 16.38%

1 Year: 96.60%

YTD: 27.36%

About Caribou Biosciences, Inc. (CRBU)

Dive into the latest financial snapshot of Caribou Biosciences, Inc. (CRBU). With a current trading price of 2.11, the stock has experienced a daily shift of +$0.12 / 5.69%. The company's market capitalization stands impressively at 208,279,200. Track its year-to-date performance, which is at 27.36%, alongside its weekly, monthly, and yearly trends.

Company Details

Employees: 97

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Selected stocks

Annexon, Inc. (ANNX)

ZOOZ Strategy Ltd. (ZOOZ)

Black Diamond Therapeutics, Inc. (BDTX)

NOVONIX Limited - American Depository Shares (NVX)

VOC Energy Trust (VOC)